Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery

Rodrigo A. Ledezma, Edris Negron, Gladell P. Paner, Chris Rjepaj, Danny Lascano, Mohammed Haseebuddin, Pankaj Dangle, Arieh L. Shalhav, Henry Crist, Jay D. Raman, G. Joel DeCastro, Lara Harik, Monika Paroder, Robert G. Uzzo, Alexander Kutikov, Scott E. Eggener

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Purpose: We aimed to determine incidence, pathologic findings, prognostic factors and clinical outcomes for patients with clinically localized papillary RCC. Methods: Demographic, clinical and pathologic findings were collected on all patients with PRCC undergoing surgery at four academic medical centers. The primary endpoint was cancer-specific survival (CSS). Relapse-free survival (RFS) and overall survival (OS) were secondary endpoints. Kaplan–Meier estimates were obtained, and Cox proportional hazard regression models were used to assess predictors of mortality and relapse. Results: We identified 626 PRCC, of which 373 (60 %) were type 1 and 253 (40 %) were type 2, with three-quarters of all tumors being pT1. Compared to patients with type 1, those with type 2 were older (mean age: 63 vs 61; p = 0.02), presented more commonly with symptoms (13 vs 7 %; p = 0.02) and had larger mean tumor size (5.2 vs 4.3 cm; p = 0.001). With a median follow-up of 41 months (IQR: 16–68), 92 patients had died of PRCC (15 %), 48 (8 %) experienced relapse, and 101 died from all causes (16 %). The estimated 5-year CSS, RFS and OS were 83, 91 and 82 %, respectively. In multivariable analysis, older age, T stage and nodal status were predictors of CSS and OS. However, PRCC subtype was not a predictor of CSS, RFS or OS. Conclusion: While patients with type 2 PRCC appear to present with more advanced disease than patients with type 1, PRCC subtype does not appear to be an independent predictor of CSS, RFS or OS for treated localized disease.

Original languageEnglish (US)
Pages (from-to)687-693
Number of pages7
JournalWorld Journal of Urology
Volume34
Issue number5
DOIs
StatePublished - May 1 2016

Keywords

  • Histological type
  • Papillary RCC
  • Prognosis
  • Survival

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery'. Together they form a unique fingerprint.

  • Cite this

    Ledezma, R. A., Negron, E., Paner, G. P., Rjepaj, C., Lascano, D., Haseebuddin, M., Dangle, P., Shalhav, A. L., Crist, H., Raman, J. D., Joel DeCastro, G., Harik, L., Paroder, M., Uzzo, R. G., Kutikov, A., & Eggener, S. E. (2016). Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World Journal of Urology, 34(5), 687-693. https://doi.org/10.1007/s00345-015-1692-3